OMER - Latest News
Omeros Corporation (OMER), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $1.04B. Trailing twelve-month P/E ratio is 12.00. Beta to the broader market is 2.66.
The article list below shows the most recent OMER headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent OMER Headlines
Omeros Q1 Earnings Call Highlights
marketbeat.com - May 14, 2026
Omeros NASDAQ: OMER reported first-quarter 2026 net income of $56. 1 million, or $0.
Omeros Corporation (OMER) Q1 2026 Earnings Call Transcript
seekingalpha.com - May 13, 2026
Omeros Corporation (OMER) Q1 2026 Earnings Call Transcript
Omeros Corporation Reports First Quarter 2026 Financial Results
businesswire.com - May 13, 2026
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the fi
Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026
businesswire.com - May 11, 2026
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the first quarter 2026 on Wed
Here's Why Omeros (OMER) is a Great Momentum Stock to Buy
zacks.com - Apr 27, 2026
Does Omeros (OMER) have what it takes to be a top stock pick for momentum investors? Let's find out.
How News Affects OMER Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track OMER's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked OMER news questions
- What is the latest OMER news headline?
- The most recent OMER headline (May 14, 2026) is "Omeros Q1 Earnings Call Highlights". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the OMER news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What OMER news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual OMER options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.